Metadata Search
Actinium Pharmaceuticals
Page 1 of 18 results
Sort by: relevance publication year Download as CSV

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

Journal Article published Jun 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 6 on pages 1024 to 1029

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (U24-CA076518) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | U.S. Department of Health and Human Services (HHSH250201200016C) | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 768 to 770

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (HHSH250201200016C) | U.S. Public Health Service (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Institutional Research | Milliman | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | American Cancer Society (86-004-26) | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Anita D'Souza, Jiaxing Huang, Parameswaran Hari

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

Journal Article published Jan 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 1 on pages 60 to 66

Research funded by Medac GmbH | Kiadis Pharma | Takeda Oncology | Sigma-Tau Pharmaceuticals | StemCyte | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | Ariad Pharmaceuticals | University of Utah | NHLBI and NCI (5U10HL069294) | Health Research, Inc. Roswell Park Cancer Institute | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA076518) | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Robert F. Cornell, Veronika Bachanova, Anita D'Souza, Kwang Woo-Ahn, Michael Martens, Jiaxing Huang, A. Samer Al-Homsi, Saurabh Chhabra, Edward Copelan, Miguel-Angel Diaz, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Mehdi Hamadani, Gerhard Hildebrandt, Rammurti T. Kamble, Mohamed Kharfan-Dabaja, Tamila Kindwall-Keller, Hillard M. Lazarus, David I. Marks, Taiga Nishihori, Richard F. Olsson, Ayman Saad, Saad Usmani, David H. Vesole, Jean Yared, Tomer Mark, Yago Nieto, Parameswaran Hari

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Apr 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 4 on pages 827 to 831

Research funded by National Cancer Institute | Patient-Centered Outcomes Research Institute | Anonymous donation to the Medical College of Wisconsin | Takeda Oncology | Medical College of Wisconsin | Millennium, the Takeda Oncology Co. | Actinium Pharmaceuticals | Cerus Corporation | Spectrum Pharmaceuticals, Inc. | Pfizer, Inc | Fred Hutchinson Cancer Research Center | Pharmacyclics, LLC | PIRCHE AG | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Immucor | Janssen Scientific Affairs, LLC | Bristol Myers Squibb Oncology | Amneal Biosciences | Kite Pharma, Inc. | Gamida Cell Ltd. | University of Minnesota | National Heart, Lung, and Blood Institute | Swedish Orphan Biovitrum, Inc. | MesoScale Diagnostics, Inc. | Juno Therapeutics; Karyopharm Therapeutics, Inc. | National Marrow Donor Program; | Atara Biotherapeutics, Inc. | Mesoblast | Medac, GmbH | Miltenyi Biotec, Inc. | Telomere Diagnostics, Inc. | Shire | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Gilead Sciences | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Sanofi Genzyme | Amgen | HistoGenetics, Inc. | bluebird bio, Inc. | Office of Naval Research (N00014-17-1-2388, N00014-16-1-2020)) | Chimerix, Inc. | Astellas Pharma US | Angiocrine Bioscience, Inc. | Incyte Corporation | Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co, Ltd. – Japan

Authors: Basem M. William, Tao Wang, Michael D. Haagenson, Katharina Fleischhauer, Michael Verneris, Katharine C. Hsu, Marcos J. de Lima, Marcelo Fernandez-Viña, Stephen R. Spellman, Stephanie J. Lee, Brian T. Hill

European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards

Journal Article published Mar 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 3 on pages 514 to 519

Research funded by National Cancer Institute | National Heart, Lung, and Blood Institute | National Institute of Allergy and Infectious Diseases | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Actinium Pharmaceuticals | Allos Therapeutics | Amgen

Authors: Chloe Anthias, Paul V. O'Donnell, Deidre M. Kiefer, Jean Yared, Maxim Norkin, Paolo Anderlini, Bipin N. Savani, Miguel A. Diaz, Menachem Bitan, Joerg P. Halter, Brent R. Logan, Galen E. Switzer, Michael A. Pulsipher, Dennis L. Confer, Bronwen E. Shaw

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age

Journal Article published Aug 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 8 on pages 1327 to 1334

Research funded by Novartis Pharmaceuticals Corporation | National Marrow Donor Program | Patient-Centered Outcomes Research Institute | Roswell Park Cancer Institute | Takeda Oncology | Medical College of Wisconsin | Pfizer | Leukemia and Lymphoma Society | Actinium Pharmaceuticals | Bristol-Myers Squibb | Cerus Corporation | Alexion Pharmaceuticals | Fred Hutchinson Cancer Research Center | WellPoint | Seattle Genetics | Sanofi | Janssen Scientific Affairs, LLC | Gamida Cell Ltd. | NHLBI and NCI (5U10HL069294) | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | Optum Healthcare Solutions, Inc. | MesoScale Diagnostics, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Genentech | Atara Biotherapeutics, Inc. | Mesoblast | Genzyme | Medac, GmbH | Telomere Diagnostics, Inc. | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (5U24-CA076518) | Gilead Sciences | Otsuka America Pharmaceutical | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Cellular Dynamics International, Inc. | Celgene | AstraZeneca | Merck | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Amgen | Office of Naval Research (N00014-15-1-0848, N00014-16-1-2020) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Bluebird Bio, Inc. | Astellas Pharma US | Incyte Corporation | Otsuka Pharmaceutical

Authors: Lynda M. Vrooman, Heather R. Millard, Ruta Brazauskas, Navneet S. Majhail, Minoo Battiwalla, Mary E. Flowers, Bipin N. Savani, Görgün Akpek, Mahmoud Aljurf, Rajinder Bajwa, K. Scott Baker, Amer Beitinjaneh, Menachem Bitan, David Buchbinder, Eric Chow, Christopher Dandoy, Andrew C. Dietz, Lisa Diller, Robert Peter Gale, Shahrukh K. Hashmi, Robert J. Hayashi, Peiman Hematti, Rammurti T. Kamble, Kimberly A. Kasow, Morris Kletzel, Hillard M. Lazarus, Adriana K. Malone, David I. Marks, Tracey A. O'Brien, Richard F. Olsson, Olle Ringden, Sachiko Seo, Amir Steinberg, Lolie C. Yu, Anne Warwick, Bronwen Shaw, Christine Duncan

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis

Journal Article published 2 Aug 2017 in British Journal of Haematology volume 182 issue 6 on pages 916 to 920

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Fresenius Biotech | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Remedy Informatics

Authors: Abraham S. Kanate, Alyssa DiGilio, Kwang W. Ahn, Monzr Al Malki, Eric Jacobsen, Amir Steinberg, Nelson Hamerschlak, Mohamed Kharfan-Dabaja, Rachel Salit, Edward Ball, Qaiser Bashir, Amanda Cashen, Daniel Couriel, Jose Diez-Martin, Emmanuel Katsanis, Yulia Linhares, Shahram Mori, Richard Nash, Attaphol Pawarode, Miguel-Angel Perales, Colin D. Phipps, Carol Richman, Bipin N. Savani, Michael Y. Shapira, Patrick Stiff, Roger Strair, Timothy S. Fenske, Sonali M. Smith, Anna Sureda, Horatiu Olteanu, Mehdi Hamadani

Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis

Journal Article published May 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 5 on pages 853 to 856

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | Ariad Pharmaceuticals | University of Utah | NHLBI and NCI (5U10HL069294) | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA076518) | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Mehdi Hamadani, Abraham S. Kanate, Alyssa DiGilio, Kwang Woo Ahn, Sonali M. Smith, Jong Wook Lee, Ernesto Ayala, Nelson Chao, Parameswaran Hari, Javier Bolaños-Meade, Ronald Gress, Niels Smedegaard Anderson, Yi-Bin Chen, Umar Farooq, Gary Schiller, Jean Yared, Anna Sureda, Timothy S. Fenske, Horatiu Olteanu

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

Journal Article published May 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 5 on pages 767 to 775

Research funded by U.S. Public Health Service (5U24-CA076518) | National Cancer Institute (HHSH250201200016C) | National Heart, Lung, and Blood Institute | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Office of Naval Research (N00014-15-1-0848, N00014-16-1-2020) | Actinium Pharmaceuticals | Alexion Pharmaceuticals | Amgen

Authors: Hien Duong Liu, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, David Rizzieri, Michael R. Grunwald, Mitchell Sabloff, Richard F. Olsson, Ashish Bajel, Christopher Bredeson, Andrew Daly, Yoshihiro Inamoto, Navneet Majhail, Ayman Saad, Vikas Gupta, Aaron Gerds, Adriana Malone, Martin Tallman, Ran Reshef, David I. Marks, Edward Copelan, Usama Gergis, Mary Lynn Savoie, Celalettin Ustun, Mark R. Litzow, Jean-Yves Cahn, Tamila Kindwall-Keller, Gorgun Akpek, Bipin N. Savani, Mahmoud Aljurf, Jacob M. Rowe, Peter H. Wiernik, Jack W. Hsu, Jorge Cortes, Matt Kalaycio, Richard Maziarz, Ronald Sobecks, Uday Popat, Edwin Alyea, Wael Saber

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

Journal Article published 15 Mar 2016 in British Journal of Haematology volume 174 issue 2 on pages 235 to 248

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Sanofi US | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Timothy S. Fenske, Kwang W. Ahn, Tara M. Graff, Alyssa DiGilio, Qaiser Bashir, Rammurti T. Kamble, Ernesto Ayala, Ulrike Bacher, Jonathan E. Brammer, Mitchell Cairo, Andy Chen, Yi-Bin Chen, Saurabh Chhabra, Anita D'Souza, Umar Farooq, Cesar Freytes, Siddhartha Ganguly, Mark Hertzberg, David Inwards, Samantha Jaglowski, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Sunita Nathan, Attaphol Pawarode, Miguel-Angel Perales, Nishitha Reddy, Sachiko Seo, Anna Sureda, Sonali M. Smith, Mehdi Hamadani